EPISODE · Jun 11, 2025 · 29 MIN
Apimeds Pharmaceuticals CEO Erik Emerson Discusses Purified Bee Venom for Knee Osteoarthritis and Other Inflammatory Conditions
from WTR Small-Cap Spotlight · host Water Tower Research
Send us Fan MailOn this week’s WTR Small-Cap Spotlight, we speak with Apimeds CEO Erik Emerson about the newly NYSE listed company and the development of Apitox, a purified honeybee venom, for knee osteoarthritis and multiple sclerosis. We discuss the therapeutic properties of bee venom and the clinical/regulatory plans to bring Apitox to the US market. Listen to learn more about Apimeds and its novel approach to treat inflammatory pain.You can listen to this episode and more on the WTR Biotech Spotlight at the links below!Apple: https://podcasts.apple.com/us/podcast/wtr-biotech-spotlight/id1795488592Spotify: https://open.spotify.com/episode/7KUMWuGavyAuDEs2527rp2?si=22adef2e0f304634
Embed this episode
NOW PLAYING
Apimeds Pharmaceuticals CEO Erik Emerson Discusses Purified Bee Venom for Knee Osteoarthritis and Other Inflammatory Conditions
No transcript for this episode yet
Similar Episodes
No similar episodes found.